Michael M Tunney Selected Research

Michael M Tunney Research Topics

Disease

29	Cystic Fibrosis (Mucoviscidosis) 02/2024 - 02/2007
26	Infections 02/2024 - 08/2003
6	Bronchiectasis 02/2024 - 03/2013
5	Inflammation (Inflammations) 01/2023 - 05/2008
3	Wounds and Injuries (Trauma) 09/2012 - 08/2008
2	Respiratory Tract Diseases (Respiratory Tract Disease) 02/2024 - 01/2024
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2024 - 12/2022
2	Lung Diseases (Lung Disease) 01/2020 - 01/2017
2	Pseudomonas Infections 07/2014 - 02/2007
1	Weight Gain 04/2022
1	Chronic Disease (Chronic Diseases) 01/2022
1	Urinary Tract Infections (Urinary Tract Infection) 01/2022
1	Burkholderia Infections 01/2019
1	Persistent Infection 01/2018
1	Pneumonia (Pneumonitis) 01/2018
1	Healthcare-Associated Pneumonia 01/2017
1	Lung Injury 01/2017
1	Communicable Diseases (Infectious Diseases) 05/2013
1	Wound Infection (Wound Infections) 09/2009
1	Candidiasis (Moniliasis) 01/2007
1	Mycoses (Diseases, Fungus) 01/2007

Drug/Important Bio-Agent (IBA)

22	Anti-Bacterial Agents (Antibiotics)IBA 02/2024 - 08/2003
5	Tobramycin (Nebcin)FDA LinkGeneric 01/2021 - 05/2012
4	Methylene Blue (Methylthioninium Chloride)FDA Link 09/2012 - 09/2009
3	murepavadinIBA 12/2021 - 01/2020
3	ivacaftorIBA 01/2021 - 09/2017
3	Fosfomycin FDA Link 11/2013 - 05/2012
3	HydrogelsIBA 09/2012 - 08/2008
3	Thymidine Monophosphate (TMP)IBA 09/2012 - 09/2009
2	Azithromycin (Zithromax)FDA LinkGeneric 01/2024 - 01/2020
2	LipopolysaccharidesIBA 01/2022 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 12/2016
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2017
2	MacrolidesIBA 01/2017 - 03/2013
2	porphine (porphin)IBA 09/2012 - 09/2009
1	CefiderocolIBA 02/2024
1	PowdersIBA 01/2024
1	elexacaftorIBA 01/2023
1	ivacaftor drug combination tezacaftorIBA 01/2023
1	Virulence Factors (Pathogenicity Factors)IBA 12/2022
1	Amoxicillin (Wymox)FDA LinkGeneric 04/2022
1	Matrix Metalloproteinases (MMPs)IBA 01/2022
1	InterleukinsIBA 01/2022
1	PeptidomimeticsIBA 12/2021
1	Phenobarbital (Luminal)FDA Link 01/2021
1	Colistin (Coly-Mycin)FDA Link 01/2021
1	Aztreonam FDA LinkGeneric 01/2021
1	C-Reactive ProteinIBA 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	LactoferrinIBA 12/2018
1	hypothiocyanite ion (OSCN-)IBA 12/2018
1	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 01/2018
1	Antimicrobial PeptidesIBA 09/2017
1	KetolidesIBA 01/2017
1	temocillinIBA 01/2017
1	Ceftazidime (Fortum)FDA LinkGeneric 02/2016
1	Chelating AgentsIBA 12/2015
1	IronIBA 12/2015
1	Heme (Haem)IBA 12/2015
1	HaptoglobinsIBA 12/2015
1	Protein Isoforms (Isoforms)IBA 12/2015
1	Volatile Fatty AcidsIBA 12/2015
1	amelubantIBA 03/2014
1	Leukotriene B4IBA 03/2014
1	DNA (Deoxyribonucleic Acid)IBA 03/2014
1	AminoglycosidesIBA 11/2013
1	Nucleic AcidsIBA 05/2013
1	poly(methyl vinyl ether-co-maleic anhydride)IBA 09/2012
1	maleic acid (maleate)IBA 09/2012
1	SodiumIBA 09/2012
1	vinyl ether (divinyl ether)IBA 09/2012
1	PolyelectrolytesIBA 09/2012
1	Vancomycin FDA LinkGeneric 07/2011
1	SolutionsIBA 03/2011
1	BoratesIBA 09/2009
1	Tolonium Chloride FDA Link 01/2007
1	Anti-Infective Agents (Microbicides)IBA 08/2003
1	Biocompatible Materials (Biomaterials)IBA 08/2003

Therapy/Procedure

7	Therapeutics 02/2024 - 02/2007
4	Drug Therapy (Chemotherapy) 09/2012 - 09/2009
3	Photochemotherapy (Photodynamic Therapy) 09/2009 - 01/2007
1	Respiratory Therapy (Therapy, Respiratory) 12/2021
1	Immunotherapy 01/2019